SEC Form 13F
| Report period | 2026-03-31 |
|---|---|
| Publicly available | 2026-05-19 |
| Reported value | $59,887,000 |
| Positions | 43 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| United States Antimony | UAMY | COM | $5,377,000 | 615,975 |
| NexGen Energy | NXE | COM | $5,095,000 | 439,205 |
| Corcept Therapeutics | CORT | COM | $4,469,000 | 110,854 |
| Nvidia | NVDA | COM | $4,322,000 | 24,780 |
| Aura Minerals, Inc. | Unresolved | COM | $4,087,000 | 50,085 |
| Nuvation Bio Inc. | NUVB | COM | $3,869,000 | 901,825 |
| Apple Computing | AAPL | COM | $3,263,000 | 12,859 |
| Intellia Therapeutics | IJR | COM | $2,822,000 | 220,107 |
| Catalyst Pharmaceuticals | CPRX | COM | $2,808,000 | 113,418 |
| Onto Innovation | ONTO | COM | $2,553,000 | 12,448 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.